MCID: OST017
MIFTS: 64

Osteomyelitis

Categories: Bone diseases, Immune diseases, Rare diseases

Aliases & Classifications for Osteomyelitis

MalaCards integrated aliases for Osteomyelitis:

Name: Osteomyelitis 12 77 54 30 56 45 15 17 74

Classifications:



External Ids:

Disease Ontology 12 DOID:1019
ICD9CM 36 730.1 730.10
MeSH 45 D010019
SNOMED-CT 69 40970001
ICD10 34 M86 M86.9

Summaries for Osteomyelitis

NIH Rare Diseases : 54 Osteomyelitis is the medical term for an infection in a bone. Signs and symptoms vary but may include bone pain, fever, chills, excessive sweating, malaise, or an open wound. People with the condition may also experience local swelling, redness, and warmth at the site of the infection. Although any bone in the body can be affected, the long bones of the arms and legs are most commonly infected in children, while the feet, spine bones, and hips are primarily affected in adults. Osteomyelitis is most often caused by a bacterial infection, although it can also be caused by a fungal infection. Risk factors for the condition include diabetes, poor blood supply, recent injury, intravenous drug abuse, surgery involving the bones, and a weakened immune system. The goal of treatment is to cure the infection and reduce damage to the bone and surrounding tissues. This may include medications to treat the infection and surgery to drain, clean and/or remove dead bone tissue.

MalaCards based summary : Osteomyelitis is related to chronic recurrent multifocal osteomyelitis and mycobacterium fortuitum, and has symptoms including bone pain and pain in limb. An important gene associated with Osteomyelitis is IL1RN (Interleukin 1 Receptor Antagonist), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs leucovorin and Ciprofloxacin have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and testes, and related phenotypes are homeostasis/metabolism and hematopoietic system

Disease Ontology : 12 A bone inflammation disease that has material basis in infection located in bone or located in bone marrow.

Wikipedia : 77 Osteomyelitis (OM) is an infection of bone. Symptoms may include pain in a specific bone with overlying... more...

Related Diseases for Osteomyelitis

Diseases related to Osteomyelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 748)
# Related Disease Score Top Affiliating Genes
1 chronic recurrent multifocal osteomyelitis 34.4 FBLIM1 IL1B LPIN2
2 mycobacterium fortuitum 32.6 CXCL8 IFNGR1
3 toxic shock syndrome 31.5 CXCL8 IFNG IL10 IL1B IL6 TNF
4 osteopetrosis, autosomal dominant 2 31.2 ACP5 CTSK TNFSF11
5 sporotrichosis 30.3 IFNG IL10
6 spinal cord injury 30.3 CXCL8 IL6 TNF
7 melioidosis 30.3 IFNG IL10 IL6 TNF
8 familial mediterranean fever 30.2 IL1B IL1RN TNF
9 endocarditis 30.2 CXCL8 IL10 IL6 TNF
10 salmonellosis 30.2 IFNG IFNGR1 IL1B
11 neuritis 30.1 IFNG IL1B TNF
12 aspergillosis 30.1 IFNG IL10 TNF
13 q fever 30.1 IFNG IL10 IL1B IL6 TNF
14 typhoid fever 30.1 IFNG IFNGR1 IL1B IL6 TNF
15 haemophilus influenzae 30.0 CXCL8 IL1B TNF
16 critical limb ischemia 30.0 IL6 TNF
17 interferon gamma, receptor 1, deficiency 30.0 IFNG IFNGR1
18 necrotizing fasciitis 30.0 CXCL8 IL1RN IL6
19 rheumatic fever 30.0 IL10 IL6 TNF
20 fasciitis 29.9 CXCL8 IL6 TNF
21 poliomyelitis 29.9 IFNG IL10 TNF
22 osteonecrosis 29.9 ACP5 BMP2 TNFSF11
23 acquired immunodeficiency syndrome 29.8 IFNG IL10 IL1B IL6 TNF
24 pneumonia 29.8 CXCL8 IL10 IL1B IL6 TNF
25 arteries, anomalies of 29.8 IL1B IL6 TNF
26 peripheral nervous system disease 29.8 IL6 SPTLC1 TNF
27 sarcoidosis 1 29.8 IFNG IL1B TNF
28 diabetes mellitus 29.8 IFNG IL1A IL1B IL1RN IL6 TNF
29 synovitis 29.8 CXCL8 IL1B IL1RN IL6 TNF TNFSF11
30 acute pyelonephritis 29.8 CXCL8 IL10 IL6
31 joint disorders 29.8 IL1B IL1RN IL6 TNF TNFSF11
32 myeloma, multiple 29.8 CXCL8 IL6 TNF TNFSF11
33 kawasaki disease 29.7 IL10 IL6 TNF
34 paracoccidioidomycosis 29.7 IFNG IL10 IL6 TNF
35 reactive arthritis 29.7 IFNG IL10 TNF
36 common variable immunodeficiency 29.7 IFNG IL10 IL6 TNF
37 meningitis 29.7 CXCL8 IFNG IL10 IL1B IL6 TNF
38 juvenile rheumatoid arthritis 29.7 IL1B IL1RN IL6 TNF
39 pericarditis 29.7 IFNG IL1B IL1RN IL6 TNF
40 spondylitis 29.7 IL1RN IL6 TNF
41 periodontitis, chronic 29.7 IL1B IL6 TNFSF11
42 arthritis 29.7 CXCL8 IFNG IL10 IL1A IL1B IL1RN
43 pyelonephritis 29.6 CXCL8 IL10 IL1B IL6 TNF
44 appendicitis 29.6 CXCL8 IL10 IL1B IL6 TNF
45 bacterial sepsis 29.6 CXCL8 IL10 TNF
46 human immunodeficiency virus infectious disease 29.6 IFNG IL10 IL6 TNF
47 acute pancreatitis 29.6 CXCL8 IL10 IL6
48 crohn's colitis 29.6 CXCL8 IFNG IL1B TNF
49 adult-onset still's disease 29.6 IL1B IL1RN IL6 TNF
50 otitis media 29.5 CXCL8 IL10 IL1B IL6 TNF

Comorbidity relations with Osteomyelitis via Phenotypic Disease Network (PDN):


Acute Cystitis Decubitus Ulcer
Deficiency Anemia Heart Disease
Hypertension, Essential Peripheral Vascular Disease
Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Osteomyelitis:



Diseases related to Osteomyelitis

Symptoms & Phenotypes for Osteomyelitis

UMLS symptoms related to Osteomyelitis:


bone pain, pain in limb

MGI Mouse Phenotypes related to Osteomyelitis:

47 (show all 15)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.33 ANO5 BMP2 CTSK IFNG IFNGR1 IL10
2 hematopoietic system MP:0005397 10.32 BMP2 CTSK FBLIM1 IFNG IFNGR1 IL10
3 immune system MP:0005387 10.28 BMP2 CTSK FBLIM1 IFNG IFNGR1 IL10
4 cardiovascular system MP:0005385 10.25 BMP2 IFNG IFNGR1 IL10 IL1A IL1B
5 cellular MP:0005384 10.24 ANO5 BMP2 CTSK FBLIM1 IFNG IFNGR1
6 growth/size/body region MP:0005378 10.24 BMP2 CTSK IFNG IL10 IL1B IL1RN
7 mortality/aging MP:0010768 10.15 BMP2 IFNG IFNGR1 IL10 IL1B IL1RN
8 craniofacial MP:0005382 10.07 BMP2 CTSK IFNG IL10 IL1B TNF
9 integument MP:0010771 10.06 IFNG IFNGR1 IL10 IL1A IL1B IL1RN
10 digestive/alimentary MP:0005381 10.05 BMP2 CTSK IFNG IFNGR1 IL10 IL6
11 nervous system MP:0003631 9.9 BMP2 CTSK IFNG IFNGR1 IL10 IL1B
12 muscle MP:0005369 9.87 ANO5 IFNG IL10 IL6 PPP3CA TNF
13 neoplasm MP:0002006 9.86 IFNG IFNGR1 IL10 IL1A IL1B IL6
14 reproductive system MP:0005389 9.7 ANO5 BMP2 IFNG IFNGR1 IL10 IL1RN
15 skeleton MP:0005390 9.36 BMP2 CTSK FBLIM1 IFNG IFNGR1 IL10

Drugs & Therapeutics for Osteomyelitis

Drugs for Osteomyelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 274)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
leucovorin Approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 58-05-9 143 6006
2
Ciprofloxacin Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 85721-33-1 2764
3
Sulfamethoxazole Approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 723-46-6 5329
4
Trimethoprim Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 738-70-5 5578
5
Vancomycin Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 1404-90-6 14969 441141
6
Daptomycin Approved, Investigational Phase 4,Phase 3,Phase 2 103060-53-3 16129629
7
Cefepime Approved, Investigational Phase 4,Phase 2,Early Phase 1 88040-23-7 5479537
8
Doxycycline Approved, Investigational, Vet_approved Phase 4,Early Phase 1 564-25-0 54671203
9
Cefotaxime Approved Phase 4,Early Phase 1 63527-52-6 5742673 456256
10
Ofloxacin Approved Phase 4,Early Phase 1 82419-36-1 4583
11
Linezolid Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 165800-03-3 441401
12
Levofloxacin Approved, Investigational Phase 4,Early Phase 1 100986-85-4 149096
13
Rifampicin Approved Phase 4,Early Phase 1 13292-46-1 5381226 5458213
14
Fusidic Acid Approved, Investigational Phase 4,Phase 2,Phase 3 6990-06-3 3000226
15
Cefoxitin Approved Phase 4,Early Phase 1 35607-66-0 441199
16
Ceftriaxone Approved Phase 4,Early Phase 1 73384-59-5 5479530 5361919
17
Dalbavancin Approved, Investigational Phase 4,Phase 3,Phase 2 171500-79-1, 91097-81-3 122186
18
Nafcillin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 985-16-0, 147-52-4 8982
19
Teicoplanin Approved, Investigational Phase 4,Phase 3,Phase 2 61036-62-2
20
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Early Phase 1 18323-44-9 29029
21
Ceftaroline fosamil Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 229016-73-3
22
Cefazolin Approved Phase 4,Phase 3 25953-19-9 33255 656510
23
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 59-30-3 6037
24
Riboflavin Approved, Investigational, Nutraceutical, Vet_approved Phase 4 83-88-5 493570
25 Gentamicins Phase 4,Early Phase 1
26 Vitamin B9 Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
27 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
28 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
29 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
30 Anti-Infective Agents, Urinary Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
31 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 2,Not Applicable,Early Phase 1
32 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
34 Vitamin B Complex Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
35 Antimalarials Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
36 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
37 Renal Agents Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
38 Topoisomerase Inhibitors Phase 4,Phase 2,Not Applicable,Early Phase 1
39 Folic Acid Antagonists Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
40 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
41 Folate Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
42 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43 Immunoglobulins, Intravenous Phase 4,Phase 3,Phase 2,Not Applicable
44 Immunoglobulins Phase 4,Phase 3,Phase 2,Not Applicable
45 Antibodies Phase 4,Phase 3,Phase 2,Not Applicable
46 Nutrients Phase 4,Phase 1
47 Trace Elements Phase 4,Phase 1
48 Micronutrients Phase 4,Phase 1
49 methicillin Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
50 Cytochrome P-450 CYP3A Inducers Phase 4,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 157)
# Name Status NCT ID Phase Drugs
1 CERAMENT™|G - Bone Healing and Re-infection Prophylaxis Unknown status NCT02128256 Phase 4
2 Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis Completed NCT02123628 Phase 4 duration of the antibiotic therapy
3 Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis Completed NCT00764114 Phase 4 antibiotic
4 Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects Completed NCT00634569 Phase 4
5 Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics Recruiting NCT03012529 Phase 4 Rifampin;Riboflavin Placebo
6 Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Recruiting NCT03426761 Phase 4 Dalbavancin;Vancomycin
7 The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials Recruiting NCT03112356 Phase 4 99mTc-Leukoscan® scintigraphy
8 Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS) Recruiting NCT03261830 Phase 4 Cefazolin;Clindamycin;Saline
9 Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia Recruiting NCT02972983 Phase 4 Daptomycin
10 ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion Enrolling by invitation NCT02972593 Phase 4
11 Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients Terminated NCT01734694 Phase 4 Vancomycin;Ceftaroline;Daptomycin;Linezolid
12 Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures Terminated NCT02400112 Phase 4 Vancomycin
13 a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis Withdrawn NCT00578890 Phase 4
14 Ceftaroline in the Treatment of Bone and Joint Infections Withdrawn NCT02005068 Phase 4 Ceftaroline
15 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
16 Platelet Gel in Systemic Sclerosis Unknown status NCT00463125 Phase 2, Phase 3 Platelet Gel
17 Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) Unknown status NCT01581593 Phase 3
18 Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006) Completed NCT01922011 Phase 3 Daptomycin;Vancomycin (or equivalent);Nafcillin (or equivalent)
19 Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. Completed NCT00366249 Phase 3 Tigecycline;Ertapenem
20 Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers Completed NCT01586481 Phase 3
21 Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) Completed NCT00538915 Phase 3
22 A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases Completed NCT01012323 Phase 3
23 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00423657 Phase 3 ceftaroline;vancomycin plus aztreonam;Placebo
24 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00424190 Phase 3 IV Vancomycin plus IV Aztreonam;Ceftaroline
25 Immune Globulin Subcutaenous (Human), 20% Completed NCT01412385 Phase 2, Phase 3
26 Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) Completed NCT00719680 Phase 3
27 Effect of Oral Probiotic Supplementation on The Rate of Hospital Acquired Infection and Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants Completed NCT01340469 Phase 3
28 Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy Completed NCT00419341 Phase 3
29 Gammagard Liquid and rHuPH20 in PID Completed NCT00814320 Phase 3
30 Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) Completed NCT01461018 Phase 3
31 Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections Completed NCT02569541 Phase 2, Phase 3 sodium fusidate
32 Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Completed NCT00322556 Phase 3 Immunoglobulins Intravenous (Human)
33 Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) Completed NCT01370616 Phase 3 Ertapenem sodium;Piperacillin/tazobactam sodium;Piperacillin/tazobactam-matching placebo;Amoxicillin/clavulunate potassium
34 Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy Completed NCT00542997 Phase 3
35 Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Completed NCT00729937 Phase 2, Phase 3 Cephalexin;Clindamycin;Trimethoprim-sulfamethoxazole
36 Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) Completed NCT01458171 Phase 3
37 Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) Completed NCT00751621 Phase 3
38 Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Completed NCT02066402 Phase 3 Tedizolid (BAY119-2631);Placebo Tedizolid (BAY119-2631);Linezolid;Placebo Linezolid
39 Staphylococcus Aureus Bacteremia Antibiotic Treatment Options Recruiting NCT01792804 Phase 3 Trimethoprim-Sulfamethoxazole;Clindamycin;Linezolid;Flucloxacillin;Cloxacillin;Vancomycin;Daptomycin;Cefazolin
40 Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID) Recruiting NCT03961009 Phase 3
41 Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia. Recruiting NCT03031210 Phase 2, Phase 3 Amoxicillin
42 Bronchiolitis in Infants Placebo Versus Dexamethasone Study Recruiting NCT03567473 Phase 3 Oral dexamethasone;Nebulized Epinephrine;Oral placebo;Nebulized normal saline
43 Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy Active, not recruiting NCT03174366 Phase 3 Denosumab
44 Study of Octanorm Subcutaneous IG in Patients With PID Active, not recruiting NCT01888484 Phase 3
45 Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency Not yet recruiting NCT03492710 Phase 3
46 Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. Terminated NCT02202135 Phase 3 Ceftaroline fosamil;Vancomycin;Aztreonam
47 Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections Terminated NCT00108433 Phase 3 Cefazolin IV;Linezolid IV;Vancomycin (IV)
48 Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis Withdrawn NCT02344511 Phase 3 Dalbavancin;cefazolin, nafcillin, oxacillin or vancomycin
49 Chronic Non-bacterial Osteomyelitis Treated With Pamidronate Unknown status NCT02594878 Phase 2 Pamidronatdinatrium
50 ASIS for Enbrel in Plaque Psoriasis Unknown status NCT02112097 Phase 1, Phase 2 Gadolinium;Gadolinium;Gadolinium;Efficacy of Enbrel subcutaneously at Week 12;Efficacy of Enbrel subcutaneously at Week 24;Efficacy of Enbrel subcutaneously at Week 36;Efficacy of Enbrel subdermally at Week 12;Efficacy of Enbrel subdermally at Week 24;Efficacy of Enbrel subdermally at Week 36;PASI 75 n(%) subcutaneously at Week 12;PASI 75 n(%) subcutaneously at Week 24;PASI 75 n(%) subcutaneously at Week 36;PASI 75 n(%) subdermally at Week 12;PASI 75 n(%) subdermally at Week 24;PASI 75 n(%) subdermally at Week 36;Adverse Reactions of Enbrel subcutaneously;Adverse Reactions of Enbrel subdermally at Week 36;Gadolinium;Gadolinium;Gadolinium

Search NIH Clinical Center for Osteomyelitis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: osteomyelitis

Genetic Tests for Osteomyelitis

Genetic tests related to Osteomyelitis:

# Genetic test Affiliating Genes
1 Osteomyelitis 30

Anatomical Context for Osteomyelitis

MalaCards organs/tissues related to Osteomyelitis:

42
Bone, Skin, Testes, Prostate, Bone Marrow, Heart, B Cells

The Foundational Model of Anatomy Ontology organs/tissues related to Osteomyelitis:

20
Bone Or

Publications for Osteomyelitis

Articles related to Osteomyelitis:

(show top 50) (show all 4037)
# Title Authors Year
1
The Dilemma of Chronic Recurrent Multifocal Osteomyelitis. ( 30616941 )
2019
2
Chronic recurrent multifocal osteomyelitis-case report of two patients and review of literature. ( 31031824 )
2019
3
New-Onset Chronic Recurrent Multifocal Osteomyelitis in a Child With Chronic Uveitis. ( 31034088 )
2019
4
Evolution of chronic recurrent multifocal osteomyelitis in a child shown by MRI. ( 30364530 )
2019
5
A rare case of emphysematous osteomyelitis of spine in uncontrolled diabetes mellitus. ( 30292343 )
2019
6
Acute exacerbation of chronic osteomyelitis triggered by aggravation of type 2 diabetes mellitus: a case report. ( 30621795 )
2019
7
Goebbels´ clubfoot: a case of osteomyelitis? ( 31111421 )
2019
8
BCG-induced discitis and osteomyelitis in a patient with a history of bladder cancer. ( 31033722 )
2019
9
Nationwide epidemiologic study for pediatric osteomyelitis and septic arthritis in South Korea: A cross-sectional study of national health insurance review and assessment service. ( 31027117 )
2019
10
The role of real-time PCR testing in the investigation of paediatric patients with community-onset osteomyelitis and septic arthritis. ( 30706296 )
2019
11
Acute osteomyelitis and septic arthritis in children: a systematic review of systematic reviews. ( 30977881 )
2019
12
Actinomyces Orbital Osteomyelitis in the Setting of Multiple Myeloma and Bisphosphonate-Related Osteonecrosis. ( 30763286 )
2019
13
Increased Fragility Fracture Rates in Older Men with Osteomyelitis. ( 30715288 )
2019
14
Osteomyelitis: A Rare Complication After Subpectoral Biceps Tenodesis. ( 30719484 )
2019
15
Discordant isolates in bone specimens from patients with recurrent foot osteomyelitis. ( 30719591 )
2019
16
Palatal actinomycosis osteomyelitis-Complication of impacted tooth in a diabetic. ( 30820977 )
2019
17
L-shaped corticotomy with bone flap sliding in the management of chronic tibial osteomyelitis: surgical technique and clinical results. ( 30755228 )
2019
18
Mucormycotic Osteomyelitis Involving the Maxilla: A Rare Case Report and Review of the Literature. ( 30805232 )
2019
19
NEMO‑binding domain peptide ameliorates inflammatory bone destruction in a Staphylococcus aureus‑induced chronic osteomyelitis model. ( 30816459 )
2019
20
Discussion: The Timing of Alloplastic Cranioplasty in the Setting of Previous Osteomyelitis. ( 30817660 )
2019
21
Chronic infectious osteomyelitis: A diagnosis beyond the skin. ( 30824262 )
2019
22
Clinical characteristics and treatment of clavicular osteomyelitis: a systematic review with pooled analysis of 294 reported cases. ( 30826202 )
2019
23
The challenge of differentiating vaso-occlusive crises from osteomyelitis in children with sickle cell disease and bone pain: A 15-year retrospective review. ( 30838073 )
2019
24
The synergistic therapeutic efficacy of vancomycin and omega-3 fatty acids alleviates Staphylococcus aureus-induced osteomyelitis in rats. ( 30841436 )
2019
25
Sphenoid Sinus Cholesteatoma-Complications and Skull Base Osteomyelitis: Case Report and Review of Literature. ( 30858746 )
2019
26
Vertebral osteomyelitis due to Candida species. ( 30868448 )
2019
27
Significance of repeat magnetic resonance imaging in diagnosing vertebral osteomyelitis. ( 30873308 )
2019
28
99m Tc-Ceftizoxime in diagnosis of diabetic foot osteomyelitis: More evidences are needed. ( 30874367 )
2019
29
Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time? ( 30699312 )
2019
30
The Impact of using the term "Diabetic Ear" for the patients with Skull Base Osteomyelitis. ( 30697101 )
2019
31
Chronic Osteomyelitis after Seven Years Neglected Bone Exposed in 12-Year-Old Boy: A Case Report. ( 30894922 )
2019
32
Osteopetrosis: presenting as maxillary osteomyelitis. ( 30895884 )
2019
33
Chronic osteomyelitis induced by the placement of dental implants on cemento-osseous dysplasia. ( 30898454 )
2019
34
Necrotizing fasciitis of the neck and head complicated with chronic osteomyelitis: Case report presentation. ( 30952495 )
2019
35
Is Bone Loss or Devascularization Associated With Recurrence of Osteomyelitis in Wartime Open Tibia Fractures? ( 30901004 )
2019
36
An untapped potential for imaging of peripheral osteomyelitis in paediatrics using [18F]FDG PET/CT -the inference from a juvenile porcine model. ( 30903403 )
2019
37
Delayed diagnosis of odontoid peg osteomyelitis with bilateral X and XII cranial nerve palsies. ( 30936340 )
2019
38
Osteomyelitis Caused by Carbapenemase-Producing Klebsiella Pneumoniae: A Diagnosis to Consider in Patients with Hematologic Malignancies and Stem Cell Transplant Recipients. ( 30962416 )
2019
39
Dental pulp exposure, periapical inflammation and suppurative osteomyelitis of the jaws in juvenile Baltic grey seals (Halichoerus grypus grypus) from the late 19th century. ( 30978237 )
2019
40
Comparison of microbiological results obtained from per-wound bone biopsies versus transcutaneous bone biopsies in diabetic foot osteomyelitis: a prospective cohort study. ( 30980264 )
2019
41
Correspondence on: A rare complication of bone marrow aspiration and trephine biopsy: Staphylococcus aureus osteomyelitis and septicaemia. ( 31020654 )
2019
42
Activity of fixed direct electrical current in experimental Staphylococcus aureus foreign-body osteomyelitis. ( 30293677 )
2019
43
Thoracolumbar Osteomyelitis Secondary to Systemic Mycobacterium Chimaera Infection Status Post Aortic Valve Replacement. ( 30293827 )
2019
44
Escherichia coli rib osteomyelitis. ( 30295859 )
2019
45
Comment on "Streptococcus anginosus Dental Implant-Related Osteomyelitis of the Jaws: An Insidious and Calamitous Entity". ( 30326230 )
2019
46
Treatment Strategy and Outcomes in Patients with Hematogenous Culture-Negative Pyogenic Vertebral Osteomyelitis. ( 30326685 )
2019
47
Successful Treatment of Saksenaea sp. Osteomyelitis by Conservative Surgery and Intradiaphyseal Incorporation of Amphotericin B Cement Beads. ( 30373790 )
2019
48
Comparison of the use of antibiotic-loaded calcium sulphate and wound irrigation-suction in the treatment of lower limb chronic osteomyelitis. ( 30447985 )
2019
49
Magnetic resonance imaging features of pubic symphysis urinary fistula with pubic bone osteomyelitis in the treated prostate cancer patient. ( 30460532 )
2019
50
The Timing of Alloplastic Cranioplasty in the Setting of Previous Osteomyelitis. ( 30601322 )
2019

Variations for Osteomyelitis

Expression for Osteomyelitis

Search GEO for disease gene expression data for Osteomyelitis.

Pathways for Osteomyelitis

Pathways related to Osteomyelitis according to GeneCards Suite gene sharing:

(show top 50) (show all 85)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.08 CTSK CXCL8 IFNG IFNGR1 IL10 IL1A
2
Show member pathways
13.77 BMP2 CXCL8 IFNG IFNGR1 IL10 IL1A
3
Show member pathways
13.6 BMP2 CXCL8 IFNG IFNGR1 IL10 IL1A
4
Show member pathways
13.47 BMP2 CXCL8 IL10 IL1A IL1B IL6
5
Show member pathways
13.47 CXCL8 IFNG IFNGR1 IL10 IL1A IL1B
6
Show member pathways
13.37 BMP2 CXCL8 IL10 IL1A IL1B IL6
7
Show member pathways
13.21 CTSK CXCL8 IFNG IFNGR1 IL10 IL1B
8
Show member pathways
13.02 CXCL8 IFNGR1 IL1B IL6 PPP3CA TNF
9
Show member pathways
13 CXCL8 IFNG IFNGR1 IL10 IL1A IL1B
10 12.88 BMP2 CXCL8 IFNG IFNGR1 IL6
11
Show member pathways
12.82 CXCL8 IFNG IL1B IL6 TNF
12
Show member pathways
12.76 BMP2 IL1A IL1B IL6 TNF
13
Show member pathways
12.74 IFNG IFNGR1 IL1A IL1B TNF
14
Show member pathways
12.72 IFNG IFNGR1 IL10 IL1A IL1B IL6
15 12.7 IFNG IL10 IL1B IL1RN PPP3CA TNF
16
Show member pathways
12.7 IFNG IL10 IL1A IL1B IL6 PPP3CA
17
Show member pathways
12.69 IFNG IFNGR1 IL10 PPP3CA TNF
18
Show member pathways
12.68 IL1A IL1B PPP3CA TNF TNFSF11
19
Show member pathways
12.66 IFNG IL10 IL1B IL6 TNF
20
Show member pathways
12.54 IFNG IFNGR1 PPP3CA TNF
21
Show member pathways
12.5 ACP5 CTSK IL10 PPP3CA TNFSF11
22
Show member pathways
12.46 CXCL8 IFNG IFNGR1 IL1A IL1B IL6
23
Show member pathways
12.43 IFNG IFNGR1 IL10 IL6
24
Show member pathways
12.42 CXCL8 IFNG IL1B IL6 TNF
25
Show member pathways
12.41 IFNG IFNGR1 IL10 IL1A IL1B TNF
26
Show member pathways
12.39 IFNG IL1B IL6 TNF
27
Show member pathways
12.38 CXCL8 IL1A IL1B IL1RN IL6 TNF
28
Show member pathways
12.36 BMP2 CXCL8 IFNG IL10 IL1A IL1B
29
Show member pathways
12.33 CXCL8 IL1A IL6 TNF
30
Show member pathways
12.33 CXCL8 IFNG IFNGR1 IL1B IL6 TNF
31
Show member pathways
12.32 IL10 IL1B IL6 PPP3CA TNF
32
Show member pathways
12.32 IFNG IFNGR1 IL1A IL1B TNF
33 12.28 CXCL8 IL10 IL1A IL1B IL1RN IL6
34 12.25 IFNG IFNGR1 IL6 TNF
35 12.24 CXCL8 IL1A IL6 PPP3CA
36
Show member pathways
12.22 IFNG IFNGR1 IL10 IL1B IL6 TNF
37
Show member pathways
12.21 BMP2 CXCL8 IFNG IFNGR1 IL10 IL1A
38 12.18 IFNG IFNGR1 IL10 IL1A IL1B IL6
39 12.17 IFNG IL1A IL1B TNF
40 12.15 CXCL8 IL10 IL1A IL1B IL6 TNF
41 12.14 BMP2 IL6 LPIN2 TNF
42
Show member pathways
12.12 IFNG IL1B IL6 TNF
43 12.1 BMP2 CXCL8 IFNG IL1A IL1B IL6
44 12.08 IFNG IL10 IL6 TNF
45 12.08 CXCL8 IFNG IL1A IL1B IL6 PPP3CA
46 12.06 CXCL8 IL1A IL1B IL6 TNF
47 12.04 CXCL8 IFNG IL10 IL1B IL6 TNF
48 12 CXCL8 IL1B TNF TNFSF11
49 11.99 IL1A IL1B IL6 TNF
50 11.96 IFNG IFNGR1 IL10 IL6

GO Terms for Osteomyelitis

Cellular components related to Osteomyelitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 BMP2 CTSK CXCL8 IFNG IL10 IL1A
2 extracellular space GO:0005615 9.36 BMP2 CTSK CXCL8 IFNG IL10 IL1A

Biological processes related to Osteomyelitis according to GeneCards Suite gene sharing:

(show top 50) (show all 57)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of protein phosphorylation GO:0001934 9.97 BMP2 IFNG IL1B TNF
2 positive regulation of gene expression GO:0010628 9.97 BMP2 IFNG IL1A IL1B IL6 PPP3CA
3 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.96 IL1B IL1RN TNF TNFSF11
4 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.93 IL1B IL6 TNF TNFSF11
5 cellular response to lipopolysaccharide GO:0071222 9.91 CXCL8 IL10 IL1B IL1RN IL6 TNF
6 defense response to Gram-positive bacterium GO:0050830 9.89 ACP5 IL6 TNF
7 ossification GO:0001503 9.89 ACP5 BMP2 TNFSF11
8 calcium-mediated signaling GO:0019722 9.88 CXCL8 PPP3CA TNFSF11
9 neutrophil chemotaxis GO:0030593 9.88 CXCL8 IL1B IL1RN
10 cellular response to organic cyclic compound GO:0071407 9.87 BMP2 IL1B TNF
11 positive regulation of JNK cascade GO:0046330 9.87 IL1B IL1RN TNF TNFSF11
12 regulation of insulin secretion GO:0050796 9.86 IFNG IL1B TNF
13 inflammatory response GO:0006954 9.86 BMP2 CXCL8 IL10 IL1A IL1B IL1RN
14 humoral immune response GO:0006959 9.85 IFNG IL6 TNF
15 interleukin-1-mediated signaling pathway GO:0070498 9.83 IL1A IL1B IL1RN
16 positive regulation of interleukin-6 production GO:0032755 9.83 IL1B IL1RN IL6 TNF
17 positive regulation of nitric oxide biosynthetic process GO:0045429 9.82 IFNG IL1B TNF
18 immune response GO:0006955 9.81 CXCL8 IFNG IL10 IL1A IL1B IL1RN
19 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.8 IL1A IL1B TNF
20 positive regulation of DNA-binding transcription factor activity GO:0051091 9.8 IL10 IL1B IL6 PPP3CA TNF TNFSF11
21 positive regulation of cytokine secretion GO:0050715 9.79 IL10 IL1A TNF
22 negative regulation of neurogenesis GO:0050768 9.77 IL1B IL6 TNF
23 bone resorption GO:0045453 9.77 ACP5 CTSK TNFSF11
24 positive regulation of osteoclast differentiation GO:0045672 9.76 IFNG TNF TNFSF11
25 positive regulation of glial cell proliferation GO:0060252 9.73 IL1B IL6 TNF
26 negative regulation of growth of symbiont in host GO:0044130 9.72 IL10 TNF
27 regulation of osteoclast differentiation GO:0045670 9.72 TNF TNFSF11
28 positive regulation of interleukin-2 biosynthetic process GO:0045086 9.72 IL1A IL1B
29 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.72 IFNG IL1B TNF
30 regulation of interferon-gamma-mediated signaling pathway GO:0060334 9.71 IFNG IFNGR1
31 negative regulation of interleukin-12 production GO:0032695 9.71 ACP5 IL10
32 response to molecule of bacterial origin GO:0002237 9.71 CXCL8 IL10
33 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.71 IL10 IL1B TNF
34 response to glucocorticoid GO:0051384 9.71 IL10 IL1RN IL6 TNF
35 negative regulation of heterotypic cell-cell adhesion GO:0034115 9.7 IL10 IL1RN
36 negative regulation of lipid storage GO:0010888 9.69 IL6 TNF
37 endothelial cell apoptotic process GO:0072577 9.69 IL10 TNF
38 positive regulation of chemokine biosynthetic process GO:0045080 9.68 IL1B TNF
39 ectopic germ cell programmed cell death GO:0035234 9.68 IL1A IL1B
40 regulation of establishment of endothelial barrier GO:1903140 9.68 IL1B TNF
41 negative regulation of cytokine secretion involved in immune response GO:0002740 9.67 IL10 TNF
42 positive regulation of neuroinflammatory response GO:0150078 9.67 IL1B IL6 TNF
43 negative regulation of interleukin-1-mediated signaling pathway GO:2000660 9.65 IL1RN IL6
44 positive regulation of fever generation GO:0031622 9.65 IL1B TNF
45 sequestering of triglyceride GO:0030730 9.64 IL1B TNF
46 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.63 IFNG IL1B TNF
47 fever generation GO:0001660 9.62 IL1A IL1B
48 receptor biosynthetic process GO:0032800 9.62 IL10 TNF
49 positive regulation of vitamin D biosynthetic process GO:0060557 9.61 IFNG TNF
50 cytokine-mediated signaling pathway GO:0019221 9.61 CXCL8 IFNGR1 IL10 IL1A IL1B IL1RN

Molecular functions related to Osteomyelitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.32 BMP2 CXCL8 IFNG IL10 IL1A IL1B
2 interleukin-1 receptor binding GO:0005149 9.13 IL1A IL1B IL1RN

Sources for Osteomyelitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....